David C. Linch
Impact in
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 165
- Acute Myeloid Leukemia Research 80
- Hematopoietic Stem Cell Transplantation 71
- Genetics 100
- Chronic Lymphocytic Leukemia Research 45
- Myeloproliferative Neoplasms: Diagnosis and Treatment 33
- Co-authors
- Rosemary E. Gale (89 shared papers)Alan K. Burnett (29 shared papers)Robert K. Hills (36 shared papers)Anthony H. Goldstone (53 shared papers)Panagiotis D. Kottaridis (19 shared papers)Anthony H. Goldstone (20 shared papers)Asim Ijaz Khwaja (28 shared papers)Rajesh Kumar Chopra (15 shared papers)
- Journals
- British Journal of Haematology (109 papers)Blood (83 papers)Journal of Clinical Oncology (22 papers)The Lancet (18 papers)Leukemia (7 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
David C. Linch
383 papers receiving 22.1k citations
David C. Linch's Hit Papers
Peers
Comparison fields: 5 of 143
- Hematology 9.3k
- Genetics 4.7k
- Pathology and Forensic Medicine 6.6k
- Oncology 6.3k
- Immunology 3.6k
Countries citing papers authored by David C. Linch
This map shows the geographic impact of David C. Linch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Linch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Linch more than expected).
Fields of papers citing papers by David C. Linch
This network shows the impact of papers produced by David C. Linch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Linch. The network helps show where David C. Linch may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Linch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 391 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials Hit paper breakdown → | 2001 | 1257 |
| 2 | Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era Hit paper breakdown → | 2010 | 1219 |
| 3 | Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial Hit paper breakdown → | 1993 | 836 |
| 4 | The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia Hit paper breakdown → | 2007 | 580 |
| 5 | 1996 | 498 | |
| 6 | Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles Hit paper breakdown → | 2013 | 403 |
| 7 | 2000 | 375 | |
| 8 | 1984 | 367 | |
| 9 | 2007 | 356 | |
| 10 | 2014 | 330 | |
| 11 | Acute myeloid leukaemia Hit paper breakdown → | 2016 | 319 |
| 12 | 2002 | 318 | |
| 13 | 2014 | 279 | |
| 14 | 2011 | 273 | |
| 15 | 2002 | 264 | |
| 16 | 2007 | 252 | |
| 17 | 2005 | 249 | |
| 18 | 2004 | 237 | |
| 19 | 1995 | 236 | |
| 20 | 1999 | 226 |
About David C. Linch
David C. Linch is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Immunology and Oncology, having authored 391 papers that have together received 23.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (114 papers), Acute Myeloid Leukemia Research (80 papers), Hematopoietic Stem Cell Transplantation (71 papers), Chronic Lymphocytic Leukemia Research (45 papers), Acute Lymphoblastic Leukemia research (37 papers), Viral-associated cancers and disorders (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers) and CNS Lymphoma Diagnosis and Treatment (28 papers). The work is most often cited by research in Hematology (9.3k citations), Genetics (4.7k citations), Pathology and Forensic Medicine (6.6k citations), Oncology (6.3k citations) and Immunology (3.6k citations). David C. Linch has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Rosemary E. Gale, Alan K. Burnett, Robert K. Hills, Anthony H. Goldstone, Panagiotis D. Kottaridis, Anthony H. Goldstone, Asim Ijaz Khwaja, Rajesh Kumar Chopra, Barry W. Hancock and David Cunningham. Their work appears in journals such as British Journal of Haematology, Blood, Journal of Clinical Oncology, The Lancet and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.